Covid-19: Brazil’s health regulator unanimously rejects Coronavac use in those under 18

ANVISA Director Sousa Freitas' vote was followed by all other 4 directors on Wednesday, August 18.

RIO DE JANEIRO, BRAZIL - Brazilian health regulatory agency (ANVISA) director Meiruze Sousa Freitas on Wednesday (18) voted against the emergency use of the Coronavac vaccine in children and adolescents aged 3 to 17.

She was joined by ANVISA directors Romison Rodrigues Mota, Alex Machado Campos and Cristiane Rose Jourdan, and by the agency's president Antonio Barra Torres, to form a unanimous vote.

ANVISA met on Wednesday to decide whether to authorize the vaccine's emergency use in children and adolescents. The Butantan Institute, Sinovac's partner in the vaccine's production, requested the inclusion of the public aged 3 . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?